Tuesday, December 20, 2016

UPDATE 1-Akebia in marketing deal for anemia drug with Japan's Otsuka

Dec 20 (Reuters) - Akebia Therapeutics Inc said it

signed a co-development and marketing deal worth up to $1

billion for its experimental anemia drug with Japan's Otsuka

Holdings Co Ltd.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)